NCT04908865: Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE) |
|
|
| Active, not recruiting | 4 | 67 | RoW | Belimumab, Standard therapy | GlaxoSmithKline | Systemic Lupus Erythematosus | 05/24 | 09/24 | | |
NCT06417502: Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry |
|
|
| Recruiting | N/A | 20000 | RoW | | Peking Union Medical College Hospital, Children's Hospital of Chongqing Medical University, Central South University, Beijing Children's Hospital, Shenzhen Children's Hospital, Children's Hospital of Nanjing Medical University, The University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI), Zhejiang University, Third Hospital of Peking University | Autoimmune Diseases, Autoinflammatory Diseases | 11/24 | 12/31 | | |
NCT05925452: To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis. |
|
|
| Recruiting | N/A | 221 | RoW | GenaKumab | Changchun GeneScience Pharmaceutical Co., Ltd. | Active Systemic Juvenile Idiopathic Arthritis | 03/28 | 06/28 | | |
